Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impacts of On-demand Versus Continuous Esomeprazole Therapy on the Symptom Control and Histological Changes of Metaplastic Esophageal Epithelium in Patients With Barrett's Esophagus (EsoBE) - a Multicentre Randomized Controlled Trial

NCT04329000 is registered in ClinicalTrials.gov with Kaohsiung Veterans General Hospital. as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04329000 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impacts of On-demand Versus Continuous Esomeprazole Therapy on the Symptom Control and Histological Changes of Metaplastic Esophageal Epithelium in Patients With Barrett's Esophagus (EsoBE) - a Multicentre Randomized Controlled Trial
Lead sponsor
Kaohsiung Veterans General Hospital.
Phase
Not applicable
Overall status
Completed
Start date
February 2, 2010
Completion date
December 8, 2019
Enrollment
218 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

barrett esophagus, proton pump inhibitor, reflux, symptom